Regulation of obesity and lipid disorders by extracts from angelica acutiloba root in high-fat diet-induced obese rats

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 223-230

  Liu, I Min ^a   Tzeng, Thing Fong ^b   Liou, Shorong Shii ^a   Chang, Chia Ju ^c  

^a TAJEN UNIVERSITY   (Taiwan)

^b Pao Chien Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

acyl CoA oxidase; Angelica acutiloba root; cytochrome P450 isoform 4A1; high fat diet; peroxisome proliferator activated receptor

Indexed keywords

ACYL COENZYME A OXIDASE; ANGELICA ACUTILOBA EXTRACT; CHOLESTEROL; CYTOCHROME P450 4A1; FAT DROPLET; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL;

ADIPOCYTE; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERLIPIDEMIC EFFECT; ANTIOBESITY EFFECT; ARTICLE; ATHEROGENIC INDEX; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; FATTY LIVER; HISTOPATHOLOGY; HYPERLIPIDEMIA; INTRAABDOMINAL FAT; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER PARENCHYMA; MALE; NONHUMAN; OBESITY; PLANT ROOT; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RISK REDUCTION; SUPPLEMENTATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANGELICA; ANIMALS; ANTI-OBESITY AGENTS; DIET, HIGH-FAT; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIPIDS; LIVER; MALE; OBESITY; PLANT EXTRACTS; RATS; RATS, WISTAR; WEIGHT GAIN;

ANGELICA ACUTILOBA; ANGELICA SINENSIS; RATTUS;

EID: 84856289542     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3532     Document Type: Article

References (32)

1. Abbott RD, Wilson PW, Kannel WB, Castelli WP,. 1988. High density lipoprotein-cholesterol, total cholesterol screening and myocardial infarction. The Framingham Study. Arterosclerosis 8: 207-211.
2. Abrass CK,. 2004. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 24: 46-53. (Pubitemid 38258276)
3. Aline M, Charles EL, Marco R, Jeanne M, Odile GN,. 2005. Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activity. Food Chem 91: 571-577.
4. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC,. 2005. High-density lipoprotein function recent advances. J Am Coll Cardiol 46: 1792-1798. (Pubitemid 41579798)
5. Björntorp P,. 1971. Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism 20: 703-713.
6. Briggs MR, Yokoyama C, Wang X, Brown MS, Goldstein JL,. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promotor. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 268: 14490-14496. (Pubitemid 23195580)
7. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR,. 1999. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474. (Pubitemid 29420675)
8. Crozier A, Jaganath IB, Clifford MN,. 2009. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26: 1001-1043.
9. Fatehi-Hassanabad Z, Chan C,. 2005. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function. Nutr Metab 2: 1-12.
10. Ferre P,. 2004. The biology of peroxisome proliferators-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes 53: S43-S50. (Pubitemid 38168692)
11. Folch J, Lees M, Sloane-Stanley GH,. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-506.
12. Friedewald WT, Levy RI, Fredrickson DS,. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18: 499-502.
13. Ginsberg HN,. 2006. Review: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 91: 383-392. (Pubitemid 43236897)
14. Hartog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhouy D,. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011. (Pubitemid 23314801)
15. Huntley AL, Ernst E,. 2003. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10: 465-476.
16. Kim HK, Nelson-Dooley C, Della-Fera MA, et al. 2006. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 136: 409-414. (Pubitemid 43228294)
17. Lee C-H, Olson P, Evans R,. 2003. Minireview: lipid metabolism, metabolic disease, and peroxisome proliferators-activated receptors. Endocrinology 144: 2201-2207. (Pubitemid 36629867)
18. Libby P,. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104: 365-372. (Pubitemid 32666962)
19. Liu IM, Tzeng TF, Liou SS, Chang CJ,. 2011. Angelica acutiloba root attenuates insulin resistance induced by high-fructose diet in rats. Phytother Res. doi: 10.1002/ptr.3403.
20. Malloy MJ, Kane JP,. 2001. A risk factor for atherosclerosis: Triglyceride-rich lipoproteins. Adv Intern Med 47: 111-136. (Pubitemid 33791976)
21. Mandard S, Muller M, Kersten S,. 2004. Peroxisome proliferators-activated receptor alpha target genes. Cell Mol Life Sci 61: 393-416. (Pubitemid 38316578)
22. McCarthy MI,. 2010. Genomics, type 2 diabetes, and obesity. N Engl J Med 363: 2339-2350.
23. Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V, Bovet P,. 2000. Dyslipidemia and abdominal obesity: an assessment in three general populations. J Clin Epidemiol 53: 393-400. (Pubitemid 30216478)
24. Padwal RS, Majumdar SR,. 2007. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369: 71-77. (Pubitemid 46027230)
25. Park CH, Yamabe N, Noh JS, Kang KS, Tanaka T, Yokozawa T,. 2009. The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice. Biol Pharm Bull 32: 1734-1740.
26. Sarker SD, Nahar L,. 2004. Natural medicine: the genus Angelica. Curr Med Chem 11: 1479-1500. (Pubitemid 38735791)
27. Sclafani A, Springer D,. 1976. Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol Behav 17: 461-471.
28. Shanmugasundaram KR, Visvanathan A, Dhandapani K, et al,. 1986. Effect of high-fat diet on cholesterol distribution in plasma lipoproteins, cholesterol esterifying activity in leucocytes, and erythrocyte membrane components studied: importance of body weight. Am J Clin Nutr 44: 805-815. (Pubitemid 17209001)
29. Tilg H, Moschen AR,. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783. (Pubitemid 44453463)
30. Tontonoz P, Kim JB, Graves RA, Spiegelman BM,. 1993. ADD1: a novel helix-loop helix-transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 13: 4753-4759.
31. Van Heek M, Compton DS, France CF, et al,. 1997. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99: 385-390. (Pubitemid 27414794)
32. Wellen KE, Hotamisligil GS,. 2005. Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119. (Pubitemid 40629025)